A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study will test two different doses of florbetapir F 18 to determine which dose is best
to image amyloid plaques in the brains of Alzheimer's Disease (AD) patients using a positron
emission tomography (PET) scanner.